MyMD Pharmaceuticals Inc
MYMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.29M
Close$
$1.71
5.7% downside
Current Fair Value
5.7% downsideOvervalued by 5.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.29 Million |
|---|---|
| Enterprise Value | $4.29 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.66 |
| Beta | 2.69 |
| Outstanding Shares | 8,059,560 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | 75541.07% |
| Return on Invested Capital | 47841.56% |
Valuation & Multiples
| P/E Ratio | -3 |
|---|---|
| PEG | 14.18 |
| Price to Sales | - |
| Price to Book Ratio | -1.81 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.46 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Q/C Technologies, Inc.
6 employees
CEO: Joshua N. Silverman Q/C Technologies, Inc. is focused on quantum-class photonic computing and blockchain infrastructure. The company has exclusive global rights to LightSolver's light-speed laser processing unit (LPU), a revolutionary light and laser-based ...